Browsing Tag
Zydus Lifesciences Limited
6 posts
Zydus Lifesciences (NSE: Zyduslife) secures FDA approval for ammonium lactate cream as U.S. generics execution deepens
Zydus Lifesciences Limited secures USFDA approval for ammonium lactate cream. Find out why this modest launch matters for U.S. generics strategy.
February 14, 2026
Zydus Lifesciences Q2 profit jumps 38% as US and China approvals sharpen global expansion strategy
Zydus Lifesciences Limited reports strong Q2 FY26 results and secures post-earnings approvals in the United States and China. Read more on investor sentiment and next steps.
November 11, 2025
Zydus Lifesciences eyes full ownership of Amplitude Surgical after landmark deal
Find out how Zydus Lifesciences is strengthening its European presence through the strategic acquisition of Amplitude Surgical SA. Read the full details here.
April 25, 2025
Zydus Lifesciences bags FDA tentative approval for Enzalutamide Tablets for prostate cancer treatment
Zydus Lifesciences Limited has secured tentative approval from the United States Food and Drug Administration (USFDA) for its…
October 2, 2024
Zydus Lifesciences receives tentative FDA approval for Letermovir tablets
In a significant development for patients undergoing bone marrow or kidney transplants, Zydus Lifesciences Limited has been granted…
March 24, 2024
Zydus Lifesciences gains FDA approval for Finasteride and Tadalafil Capsules
In a significant development for the pharmaceutical industry, Zydus Lifesciences Limited, previously known as Cadila Healthcare Limited, has…
March 17, 2024